drugset / Trial / NCT02699125

Treatment of OSA Associated Hypertension With Alpha 2 Agonist or Diuretic

NCT02699125

Phase 4 Completed 41 enrolled University of California, San Diego
RandomizedCrossoverTriple-blindTreatment

Summary

Patients who have obstructive sleep apnea (OSA) frequently stop breathing while they sleep. They often develop high blood pressure. We are not sure what drug is best to treat the high blood pressure. This study will give the patients guanfacine or hydrochlorothiazide (HCTZ) for 6 weeks after 2 weeks of placebo. The blood pressure response will be evaluated by 24 hour monitoring.

Timeline

Start
2015-01
Primary completion
2016-06
Completion
2016-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Guanfacine Small molecule 2 mg
Subject Hydrochlorothiazide Unknown 25 mg